Particulate vaccine candidate for Japanese encephalitis induces long-lasting virus-specific memory T lymphocytes in mice

Vaccine

Volumn 15, Issue 3, 1997, Pages 281-286

  Konishi, Eiji ^a   Win, Khin Sane ^a   Kurane, Ichiro ^b   Mason, Peter W ^c   Shope, Robert E ^d,e   Ennis, Francis A ^b  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Japanese encephalitis; T lymphocyte; vaccine

Indexed keywords

JAPANESE ENCEPHALITIS VACCINE; NEUTRALIZING ANTIBODY; VIRUS ENVELOPE PROTEIN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; IN VITRO STUDY; JAPANESE ENCEPHALITIS VIRUS; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VACCINATION; VACCINIA VIRUS; VIRUS RECOMBINANT;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; CYTOTOXICITY, IMMUNOLOGIC; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 0031052753     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00180-6     Document Type: Article

References (46)

1. Putnak, J.R. and Schlesinger, J.J. Protection of mice against yellow fever virus encephalitis by immunization with a vaccinia virus recombinant encoding the yellow fever virus nonstructural proteins, NS1, NS2a and NS2b. J. Gen. Virol. 1990, 71, 1697-1702
2. Yasuda, A., Kimura-Kuroda, J., Ogimoto, M. et al. Induction of protective immunity in animals vaccinated with recombinant vaccinia viruses that express PreM and E glycoproteins of Japanese encephalitis virus. J. Virol. 1990, 64, 2788-2795
3. Jan, L.R., Yang, C.S., Henchal, L.S. et al. Increased immunogenicity and protective efficacy in outbred and inbred mice by strategic carboxyl-terminal truncation of Japanese encephalitis virus envelope glycoprotein. Am. J. Trop. Med. Hyg. 1993, 48, 412-423
4. Jacobs, S.C., Stephenson, J.R. and Wilkinson, G.W. Protection elicited by a replication-defective adenovirus vector expressing the tick-borne encephalitis virus non-structural glycoprotein NS1. J. Gen. Virol. 1994, 75, 2399-2402
5. Sumiyoshi, H., Tignor, G.H. and Shope, R.E. Characterization of a highly attenuated Japanese encephalitis virus generated from molecularly cloned cDNA. J. Infect. Dis. 1995, 171, 1144-1151
6. Zhang, Y.M., Hayes, E.P., McCarty, T.C. et al. Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis. J. Virol. 1988, 62, 3027-3031
7. McCown, J., Cochran, M., Putnak, R. et al. Protection of mice against lethal Japanese encephalitis with a recombinant baculovirus vaccine. Am. J. Trop. Med. Hyg. 1990, 42, 491-499
8. Deubel, V., Bordier, M., Megret, F., Gentry, M.K., Schlesinger, J.J. and Girard, M. Processing, secretion, and immunoreactivity of carboxy terminally truncated dengue-2 virus envelope proteins expressed in insect cells by recombinant baculoviruses. Virology 1991, 180, 442-447
9. Despres, P., Dietrich, J., Girard, M. and Bouloy, M. Recombinant baculoviruses expressing yellow fever virus E and NS1 proteins elicit protective immunity in mice. J. Gen. Virol. 1991, 72, 2811-2816
10. Qu, X., Chen, W., Maguire, T. and Austin, F. Immunoreactivity and protective effects in mice of a recombinant dengue 2 Tonga virus NS1 protein produced in a baculovirus expression system. J. Gen. Virol. 1993, 74, 89-97
11. Feighny, R., Burrous, J. and Putnak, R. Dengue type-2 virus envelope protein made using recombinant baculovirus protects mice against virus challenge. Am. J. Trop. Med. Hyg. 1994, 50, 322-328
12. Eckels, K.H., Dubois, D.R., Summers, P.L. et al. Immunization of monkeys with baculovirus-dengue type-4 recombinants containing envelope and nonstructural proteins: evidence of priming and partial protection. Am. J. Trop. Med. Hyg. 1994, 50, 472-478
13. Delenda, C., Frenkiel, M.P. and Deubel, V. Protective efficacy in mice of a secreted form of recombinant dengue-2 virus envelope protein produced in baculovirus infected insect cells. Arch. Virol. 1994, 139, 197-207
14. Mason, P.W., Pincus, S., Foumier, M.J., Mason, T.L., Shope, R.E. and Paoletti, E. Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection. Virology 1991, 180, 294-305
15. Konishi, E., Pincus, S., Fonseca, B.A.L., Shope, R.E., Paoletti, E. and Mason, P.W. Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus. Virology 1991, 185, 401-410
16. Pincus, S., Mason, P.W., Konishi, E. et al. Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis. Virology 1992, 187, 290-297
17. Fonseca, B.A.L, Pincus, S., Shope, R.E., Paoletti, E. and Mason, P.W. Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice. Vaccine 1994, 12, 279-285
18. Allison, S.L., Stadler, K., Mandl, C.W., Kunz, C. and Heinz, F.X. Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form. J. Virol. 1995, 69, 5816-5820
19. Konishi, E., Pincus, S., Paoletti, E., Shope, R.E., Burrage, T. and Mason, P.W. Mice immunized with a subviral particle containing the Japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection. Virology 1992, 188, 714-720
20. Igarashi, A. Isolation of a Singh's Aedes albopictus cell clone sensitive to Dengue and Chikungunya viruses. J. Gen. Virol. 1978, 40, 531-544
21. Mason, P.W. Maturation of Japanese encephalitis virus glycoproteins produced by infected mammalian and mosquito cells. Virology 1989, 169, 354-364
22. Rothman, A.L., Kurane, I., Zhang, Y.M., Lai, C.J. and Ennis, F.A. Dengue virus-specific murine T-lymphocyte proliferation: serotype specificity and response to recombinant viral proteins. J. Virol. 1989, 63, 2486-2491
23. Konishi, E., Kurane, I., Mason, P.W., Innis, B.L. and Ennis, F.A. Japanese encephalitis virus-specific proliferative responses of human peripheral blood T lymphocytes. Am. J. Trop. Med. Hyg. 1995, 53, 278-283
24. Konishi, E., Pincus, S., Paoletti, E., Shope, R.E. and Mason, P.W. Avipox virus-vectored Japanese encephalitis virus vaccines: use as vaccine candidates in combination with purified subunit immunogens. Vaccine 1994, 12, 633-638
25. Haffar, O.K., Smithgall, M.D., Moran, P.A., Travis, B.M., Zarling, J.M. and Hu, S.L. HIV-specific humoral and cellular immunity in rabbits vaccinated with recombinant human immunodeficiency virus-like gag-env particles. Virology 1991, 183, 487-495
26. Rovinski, B., Haynes, J.R., Cao, S.X. et al. Expression and characterization of genetically engineered human immuno-deficiency virus-like particles containing modified envelope glycoproteins: implications for development of a cross-protective AIDS vaccine. J. Virol. 1992, 66, 4003-4012
27. Luo, L., Li, Y., Cannon, P.M., Kim, S. and Kang, C.Y. Chimeric gag-V3 virus-like particles of human immunodeficiency virus induce virus-neutralizing antibodies. Proc. natn. Acad. Sci. U.S.A. 1992, 89, 10527-10531
28. Shen, L., Mazzara, G.P., DiSciullo, S.O., Panicali, D.L. and Letvin, N.L. Immunization with lentivirus-like particles elicits a potent SIV-specific recall cytotoxic T-lymphocyte response in rhesus monkeys. AIDS Res. Hum. Retroviruses 1993, 9, 129-132
29. Kimbauer, R., Booy, F., Cheng, N., Lowy, D.R. and Schiller, J.T. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc. natn. Acad. Sci. U.S.A. 1992, 89, 12180-12184
30. Breitburd, F., Kirnbauer, R., Hubbert, N.L. et al. Immunization with virus-like particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J. Virol. 1995, 69, 3959-3963
31. Martinez, C., Dalsgaard, K., Lopez-de-Turiso, J.A., Cortes, E., Vela, C. and Casal, J.I. Production of porcine parvovirus empty capsids with high immunogenic activity. Vaccine 1992, 10, 684-690
32. Redmond, M.J., Ijaz, M.K., Parker, M.D. et al. Assembly of recombinant rotavirus proteins into virus-like particles and assessment of vaccine potential. Vaccine 1993, 11, 273-281
33. Roy, P., Bishop, D.H., LeBlois, H. and Erasmus, B.J. Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection. Vaccine 1994, 12, 805-811
34. Nagesha, H.S., Wang, L.F., Hyatt, A.D., Morrissy, C.J., Lenghaus, C. and Westbury, H.A. Self-assembly, antigenicity, and immunogenicity of the rabbit haemorrhagic disease virus (Czechoslovakian strain V-351) capsid protein expressed in baculovirus. Arch. Virol. 1995, 140, 1095-1108
35. Konishi, E. and Mason, P.W. Proper maturation of the Japanese encephalitis virus envelope glycoprotein requires cosynthesis with the premembrane protein. J. Virol. 1993, 67, 1672-1675
36. Yamada, A., Young, J.F. and Ennis, F.A. Influenza virus subtype-specific cytotoxic T lymphocytes lyse target cells coated with a protein produced in E. coli. J. Exp. Med. 1985, 162, 1720-1725
37. Yamada, A., Ziese, M.R., Young, J.F., Yamada, Y.K. and Ennis, F.A. Influenza virus hemagglutinin-specific cytotoxic T cell response induced by polypeptide produced in Escherichia coli. J. Med. Exp. 1985, 162, 663-674
38. + cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMS. Nature 1990, 344, 873-875
39. Malik, A., Gross, M., Ulrich, T. and Hoffman, S.L. Induction of cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein by immunization with soluble recombinant protein without adjuvant. Infect. Immun. 1993, 61, 5062-5066
40. Hosaka, Y., Sasao, F. and Ohara, R. Cell-mediated lysis of heat-inactivated influenza virus-coated murine targets. Vaccine 1985, 3, 245-251
41. + cytotoxic T lymphocytes. J. Exp. Med. 1992, 176, 1739-1744
42. + cytotoxic T cells in vivo by carrier-free HIV synthetic peptides. Proc. natn. Acad. Sci. U.S.A. 1991, 88, 9448-9452
43. Wharton, S.A., Calder, L.J., Ruigrok, R.W., Skehel, J.J., Steinhauer, D.A. and Wiley, D.C. Electron microscopy of antibody complexes of influenza virus haemagglutinin in the fusion pH conformation. EMBO. JI 1995, 14, 240-246
44. Iinuma, H., Nerome, K., Yoshioka, Y. and Okinaga, K. Characteristics of cytotoxic T lymphocytes directed to influenza virus haemagglutinin elicited by immunization with muramyldipeptide-influenza liposome vaccine. Scand. J. Immun. 1995, 41, 1-10
45. Layton, G.T., Harris, S.J., Gearing, A.J. et al. Induction of HIV-specific cytotoxic T lymphocytes in vivo with hybrid HIV-1 V3:Ty-virus-like particles. J. Immun. 1993, 151, 1097-1107
46. Reis e Sousa, C. and Germain, R.N. Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J. Exp. Med. 1995, 182, 841-851